
    
      This study is for patients with previously diagnosed advanced non small cell lung cancer
      (NSCLC, stage IIIb or IV) who had progression of their disease during or after first-line
      therapy containing platinum. Patients will be assigned to receive 6 cycles of therapy from
      one of four treatment regimens:

        -  docetaxel

        -  docetaxel + vinorelbine

        -  docetaxel + gemcitabine

        -  docetaxel + capecitabine
    
  